FDA Approved Drugs

FDA-Approved JAK Inhibitors for Alopecia Areata: Clinical Impact and 2026 Treatment Guidelines

As of 2026, the treatment of severe alopecia areata has been transformed by FDA-approved Janus kinase (JAK) inhibitors, including baricitinib (Olumian...